KLP Kapitalforvaltning AS Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA)

KLP Kapitalforvaltning AS acquired a new stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 2,100 shares of the company’s stock, valued at approximately $36,000. A number of other hedge funds also recently modified their holdings of the stock. American Century Companies Inc. grew its […]